MedPath

Pilot study on the effect of ozone exposure on lung functio

Not Applicable
Recruiting
Conditions
reduced lung function
lung inflammation
Respiratory - Other respiratory disorders / diseases
Inflammatory and Immune System - Other inflammatory or immune system disorders
Registration Number
ACTRN12621000891820
Lead Sponsor
The New Zealand Institute for Plant and Food Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

Healthy male and female (50/50) non-pregnant individuals 18-40 years of age with normal lung function at baseline will be selected

Exclusion Criteria

If they are unwilling or unable to provide informed written consent or comply with the study procedures.
• If they have a diagnosed health conditions that impair their lung function (asthma, COPD, fibrosis), diabetes or cardiovascular disease.
• If they smoke.
If they work in an environment where they are exposed to high levels of occupational respiratory irritants such as ozone or fine particulate matter (eg welders)
In addition, participants will also be excluded if they have the following health conditions: (i) blood borne diseases (e.g. hepatitis), (ii) clinically diagnosed high/low blood pressure, (iii) recent bacterial or viral illness or (iv) are taking medication that affects the properties of blood (e.g. blood clotting)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath